par Bion, J.;Vincent, Jean Louis 
;Angood, P.
Référence Wiener Klinische Wochenschrift, 118, 1-2, page (63)
Publication Publié, 2006-02
;Angood, P.Référence Wiener Klinische Wochenschrift, 118, 1-2, page (63)
Publication Publié, 2006-02
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bion, J.; Vincent, Jean Louis; Angood, P. |
| Informations sur la publication: | Wiener Klinische Wochenschrift, 118, 1-2, page (63) |
| Statut de publication: | Publié, 2006-02 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Anti-Infective Agents -- therapeutic use |
| Clinical Trials as Topic -- ethics | |
| Conflict of Interest | |
| Drug Approval | |
| Drug Industry -- ethics | |
| Ethicists | |
| Ethics, Business | |
| Ethics, Pharmacy | |
| Europe | |
| Humans | |
| Protein C -- adverse effects -- therapeutic use | |
| Recombinant Proteins -- adverse effects -- therapeutic use | |
| Sepsis -- prevention & control | |
| United States | |
| Note générale: | Comment |
| Letter | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0043-5325 |
| info:doi/10.1007/s00508-006-0528-y | |
| info:pmid/16489529 |
